methylation-specific PCR
Previse Completes Validation Study of Barrett's Esophagus Test, Sees Path to Guideline Inclusion
Premium
The epigenetic risk stratification test demonstrated the potential to decrease surveillance among some patients and increase it among others.
Through a US-based subsidiary, the South Korean firm has received breakthrough device designation for its bladder cancer test that could accelerate it to market.
Inex Innovate to Launch PCR-Based Endometrial Cancer Detection Test
The Singapore-based company plans to launch the epiHera test in August, following interim results from a clinical study with researchers at the Chinese University of Hong Kong.
BGI Genomics, Zentya Partner to Launch PCR Fecal Test for Colorectal Cancer in Slovakia
ColoTect 1.0 is a fecal assay that can trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples using methylation-specific PCR technology.
The company aims to release an initial tissue-based prognostic this year, with a less-invasive sponge-sampling version for screening high-risk individuals to follow in 2023.